학술논문
Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg/day) in a QID regimen
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
10591311